Skip to main content
. 2018 Aug 23;293(41):15840–15854. doi: 10.1074/jbc.RA118.005062

Table 2.

Effects of alanine substitutions in RAMP1:CLR on AM2/IMD activation of cAMP signaling

*, p < 0.05.

Receptor mutant WT pEC50 ± S.E. (n) Mutant pEC50 ± S.E. (n)a -Fold change Mutant Emax (% of WT) ± S.E. (n)b
CLR T37A 8.43 ± 0.10 (3) 6.91 ± 0.06* (3) 33 98.9 ± 3.08 (3)
CLR W72A 8.33 ± 0.08 (3) 6.51 ± 0.23* (3) 146 121.1 ± 17.1 (3)
CLR F92A 8.50 ± 0.08 (3) 6.22 ± 0.14* (3) 191 55.9 ± 19.5 (3)
CLR D94A 8.47 ± 0.03 (3) 7.35 ± 0.11* (3) 12 131.9 ± 8.52 (3)
CLR F95A 8.36 ± 0.05 (3) 6.21 ± 0.16* (3) 143 108.1 ± 15.2 (3)
CLR H114A 8.27 ± 0.09 (3) 6.89 ± 0.07* (3) 24 98.2 ± 21.2 (3)
CLR R119A 8.53 ± 0.14 (5) 6.61 ± 0.04* (5) 83 100.9 ± 22.2 (5)
CLR W121A 8.29 ± 0.10 (3) <5.3 (3) >1,000 Undeterminable
CLR Y124A 8.41 ± 0.04 (3) 6.63 ± 0.09* (3) 60 37.1 ± 7.49* (5)
RAMP1 W84A 8.38 ± 0.07 (4) 7.32 ± 0.15* (3) 12 81.3 ± 9.52 (3)

a Statistical significance of pEC50 values was determined by a paired t test comparing the mutant pEC50 with the WT pEC50.

b Statistical significance of Emax values was determined by a ratio paired t test comparing the mutant Emax with the WT Emax before normalization.